OXiGENE, Inc. – Separation Agreement and Release (August 6th, 2015)
THIS SEPARATION AGREEMENT AND RELEASE (Agreement) is made and entered into by and between Barbara Riching (Employee) and OXiGENE, Inc. (Company), and inures to the benefit of each of Companys current, former and future, as applicable, subsidiaries, affiliates, related entities, successors, officers, directors, shareholders, agents, employees and assigns. The term Parties used in this Agreement means Company and Employee collectively.
OXiGENE, Inc. – Employment Agreement Amendment (November 13th, 2014)
OXiGENE, Inc. (the Company) and Barbara D. Riching (Employee) hereby agree to amend the February 27, 2013 employment agreement between Company and Employee, for good and valuable consideration, the receipt and sufficiency of which are hereby mutually acknowledged, to add the following provisions:
OXiGENE, Inc. – Oxigene, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law (September 20th, 2013)
OXiGENE, Inc. – Vacation: You Will Be Entitled to 12 Days of Paid Vacation Per Year (Prorated From 15 Days). Your Vacation Accrues Based on the Number of Days You Have Been Employed by the Company. Confidentiality: The Company Considers the Protection of Its Confidential Information, Proprietary Materials and Goodwill to Be Extremely Important. Consequently, as a Condition of This Offer of Employment, You Are Required to Sign the Employee Proprietary Information and Inventions Agreement (The Agreement) Enclosed With This Letter. (February 28th, 2013)
If the foregoing satisfactorily reflects the mutual understanding between you and the Company, kindly sign and return to the Company the enclosed copy of this letter. This offer of employment is conditioned on the results of your reference check, receiving your acceptance by February , 2013, and on your eligibility to work in the United States.